Kaken Pharmaceutical Co Ltd
TSE:4521
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kaken Pharmaceutical Co Ltd
TSE:4521
|
JP |
|
C
|
CITIC Ltd
XBER:CPF
|
CN |
|
E
|
Elders Ltd
F:FTZ
|
AU |
|
Infotel SA
PAR:INF
|
FR |
|
R
|
Redbank Copper Ltd
ASX:RCP
|
AU |
|
A
|
Air China Ltd
SWB:AD2
|
CN |
|
D
|
Digital Turbine Inc
F:4MD
|
US |
|
Thales SA
F:CSF0
|
FR |
|
I
|
Industrial and Commercial Bank of China Ltd
DUS:ICK
|
CN |
|
S
|
Sunrise Communications AG
SIX:SUNN
|
CH |
|
D
|
Dunelm Group PLC
XBER:DFQ
|
UK |
|
Linde PLC
NASDAQ:LIN
|
UK |
|
T
|
Ted Baker PLC
F:TEB
|
UK |
|
D
|
DS Smith PLC
F:1KR
|
UK |
|
IDP Education Ltd
F:03F
|
AU |
Wall St Price Targets
Price Targets Summary
Kaken Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Kaken Pharmaceutical Co Ltd is 4 666.5 JPY with a low forecast of 4 040 JPY and a high forecast of 5 880 JPY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Kaken Pharmaceutical Co Ltd's stock price target?
Price Target
4 666.5
JPY
According to Wall Street analysts, the average 1-year price target for Kaken Pharmaceutical Co Ltd is 4 666.5 JPY with a low forecast of 4 040 JPY and a high forecast of 5 880 JPY.
What is the Revenue forecast for Kaken Pharmaceutical Co Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 3 years is 2%.
What is the Gross Profit forecast for Kaken Pharmaceutical Co Ltd?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 2 years is 0%.
What is the Pre-Tax Income forecast for Kaken Pharmaceutical Co Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -13%. The projected CAGR for the next 2 years is 3%.
What is the Net Income forecast for Kaken Pharmaceutical Co Ltd?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Net Income has been -10%. The projected CAGR for the next 2 years is -1%.
